Fayem Johnson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fayem Johnson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fayem Johnson Today - Breaking & Trending Today

Puma Biotechnology, Inc. Announces Presentation of Findings from a Phase I/II Study of Alisertib and Pembrolizumab for Rb-Deficient Head and Neck Squamous Cell Carcinomas at the 2023 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting

Published: October 14, 2023

Puma Biotechnology, Inc. announced the poster presentation of a Phase I/II trial of alisertib plus pembrolizumab for the treatment of patients with Rb-deficient head and neck squamous cell carcinoma...

Source: marketscreener.com

Puma Biotechnology Announces Presentation of Findings from a Phase I/II Study of Alisertib and Pembrolizumab for Rb-Deficient Head and Neck Squamous Cell Carcinomas at the 2023 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting

Published: October 14, 2023

Puma Biotechnology, Inc. , a biopharmaceutical company, announced the poster presentation of a Phase I/II trial of alisertib plus pembrolizumab for the treatment of patients with Rb-deficient head...

Source: marketscreener.com

Puma Biotechnology Announces Presentation of Findings from a Phase I/II Study of Alisertib and Pembr

Published: October 14, 2023

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced the poster presentation of a Phase I/II trial of alisertib plus pembrolizumab for the treatment of patients with Rb-deficient head and neck squamous cell carcinoma (Clinicaltrials.gov identifier NCT04555837)...

Source: pharmiweb.com